CrossrefInfokarte
Pituitary Macroadenoma Development in Transgender Women Receiving Gender-Affirming Hormone Therapy: A Call for Baseline Prolactin Screening Prior to Initiation of Therapy
AACE Endocrinology and Diabetes · 2026-10
DOI: 10.1016/j.aed.2026.09.025 ↗Abstract
Kein Abstract verfügbar.
EUVIMED